Disclose the therapy treated in subject by giving disease and illness that CFTR reinforcing agents are valuably treated.The method includes giving the compound (I) or (II) or its pharmaceutically acceptable salt of the amount within the scope of about 200 mg of about 50 mg of the subject once a day.The present invention also provides the purposes of composition and this composition comprising compound (I) or (II) in method.Or。
